SCHEMBL8891409

SCHEMBL8891409

COc1ccc(-c2cc(C(=O)Cl)ccc2OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.54
ALDH1A1 P00352 3/20 0.51
GAA P10253 2/20 0.51
SYK P43405 4/20 0.51
AURKB Q96GD4 2/20 0.51
INCENP Q9NQS7 2/20 0.51
LMNA P02545 1/20 0.50
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16712929 0.88 BACE1 (0.56) BACE1ALDH1A1GAASYKAURKB
SCHEMBL16712926 0.88 POLB (0.49) ALDH1A1LMNAMAPTKDM4EHPGD
SCHEMBL6248458 0.86 LMNA (0.68) BACE1ALDH1A1GAASYKAURKB
SCHEMBL16712923 0.86 LMNA (0.51) ALDH1A1SYKAURKBINCENPLMNA
SCHEMBL6934114 0.84 HSP90AA1 (0.58) ALDH1A1SYKLMNAMAPTHTT
SCHEMBL6642702 0.81 CYP1A2 (0.54) BACE1ALDH1A1GAALMNAMAPT
SCHEMBL15654606 0.81 ALDH1A1 (0.63) BACE1ALDH1A1GAASYKAURKB
SCHEMBL6667738 0.79 CES2 (0.59) ALDH1A1LMNAMAPTKDM4EHPGD
SCHEMBL2039734 0.79 ALDH1A1 (0.63) BACE1ALDH1A1GAALMNAMAPT
SCHEMBL29788029 0.79 ALDH1A1 (0.63) BACE1ALDH1A1GAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160272584-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS UNIVERSITY OF KANSAS (US) 2016-09-22 US disclosed
WO-2015070091-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS THE UNIVERSITY OF KANSAS (US) 2015-05-14 WO disclosed
WO-1997003967-A1 SUBSTITUTED AROMATIC COMPOUNDS AND THEIR PHARMACEUTICAL USE RHONE-POULENC RORER LIMITED (GB) 1997-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272584-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P BACE1 3079/4885ALDH1A1 847/4885GAA 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.